Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) |
Dec. 31, 2022 |
Dec. 31, 2021 |
|---|---|---|
| Income Tax Disclosure [Abstract] | ||
| Amortization | $ 375,821 | $ 460,537 |
| Net operating loss carryforward | 15,445,916 | 15,164,992 |
| Allowance for doubtful accounts | 387,818 | 401,436 |
| Charitable contributions | 644 | 644 |
| Stock options | 1,003,453 | 1,003,453 |
| Accrued liabilities | 1,826,839 | 1,711,890 |
| HHS Provider Relief Funds | 67,685 | |
| Employee retention credit | 292,282 | 292,282 |
| HTS and AMSG basis difference | 878,709 | 878,709 |
| Deferred state tax asset | 4,089,682 | 3,683,024 |
| Total deferred income tax assets | 24,368,849 | 23,596,967 |
| Depreciation | (583,812) | 691,456 |
| Deferred tax asset, net | 23,785,037 | 22,905,511 |
| Less: valuation allowance | (23,785,037) | (22,905,511) |
| Net deferred tax assets |
| X | ||||||||||
- Definition Depreciation. No definition available.
|
| X | ||||||||||
- Definition Deferred tax assets amortization. No definition available.
|
| X | ||||||||||
- Definition VisualMed basis difference. No definition available.
|
| X | ||||||||||
- Definition Employee retention credit. No definition available.
|
| X | ||||||||||
- Definition HHS Provider Relief Funds. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|